Track the DAVITA HEALTHCARE PARTNERS INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €6.6bn. The latest transaction was filed on 5 January 2016 (Attribution). Among the most active insiders: Arway Pamela M. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
DAVITA HEALTHCARE PARTNERS INC. is an American healthcare company primarily focused on kidney care services, particularly dialysis. It provides care for patients suffering from chronic and acute kidney failure.